Pancreatic Cancer Research

ResearcherSir Run Run Shaw HospitalActive in the last 2 years

Da Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4895-1185; OpenAlex author ID A5100384538. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 3

  1. Diagnosis methods for pancreatic cancer with the technique of deep learning: a review and a meta-analysis. Co-author DOI 10.3389/fonc.2025.1597969↗
  2. LncRNAs associated with vascular mimicry establish a novel molecular subtype and prognostic model for pancreatic cancer. Co-author DOI 10.1007/s00432-023-05015-3↗
  3. Efficacy and safety of gemcitabine plus anti-angiogenesis therapy for advanced pancreatic cancer: a systematic review and meta-analysis of clinical randomized … Last author DOI 10.7150/jca.26672↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dongrui Li · 1 shared paper, 2025 · strength 0.28
  2. Yuanbo Bi · 1 shared paper, 2025 · strength 0.28
  3. Haitao Lv · 1 shared paper, 2025 · strength 0.28
  4. Anlai Ji · 1 shared paper, 2023 · strength 0.22
  5. Qiang Zhang · 1 shared paper, 2023 · strength 0.22
  6. Feiyu Mao · 1 shared paper, 2023 · strength 0.22
  7. Yanling Wang · 1 shared paper, 2019 · strength 0.10
  8. Haibo Xing · 1 shared paper, 2019 · strength 0.10
  9. Mengting Tong · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.